
Comprehensive Thyroid & Lung
The Archer® FusionPlex Comprehensive Thyroid and Lung (CTL) panel is a targeted next-generation sequencing (NGS) product to detect gene fusions, single-nucleotide variant (SNV), indels, splicing and gene expression in 36 genes associated with lung and thyroid cancers. This panel complements the Archer VariantPlex® CTL panel for comprehensive mutation profiling of fusions, copy number variations (CNVs) and variants.
Thank You
- Key Features
- Specifications
- Gene Targets
- Additional Resources

Comprehensive Fusion Detection
AMP chemistry utilizes open-ended targeted amplification to identify gene fusions whether or not the fusion partner is known.

Splice Variants
Detect cancer-associated isoforms and alternative splicing events.

Low Input
Purpose-built for wide sample type compatibility, including low-input and degraded samples such as FFPE tissue.

Simple, Lyophilized Workflow
Easy-to-handle lyophilized reagents and a simple workflow to minimize errors and reduce turnaround time.
Properties
Specifications
Gene Targets
36
Input cfDNA Required
≤10ng
Unique Molecular On-Target %
>93%
Hands-On Time
2.5 Hour
Total Time
9 Hour
Platform
Illumina® and Ion Torrent™
Sample Types
Fresh frozen and FFPE
Input recommendations for FFPE samples vary depending on Archer PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening
Product Information
Illumina
- AB0007 - 8-reactions
- AB0061 - 48-reactions Learn More
- AB0031 - 16-reactions – Ask about our starter panel
- Download Protocol
ION TORRENT™
- AB0010 - 8-reactions
- AB0062 - 48-reactions Learn More
- AB0030 - 16-reactions – Ask about our starter panel
- Download Protocol
Archer® Analysis
Contact Us
